HuagongsheHuagongshe Chemistry Print Report · For research reference only
3-Ethynylimidazo[1,2-b]pyridazine → 3-(2-(2-Methyl-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-2-yl)phenyl)ethynyl)imidazo[1,2-b]pyridazine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 3-Ethynylimidazo[1,2-b]pyridazine | HCID 46838760 | — |
| Reactant | 2-(3-Iodo-4-methylphenyl)-6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazole | HCID 86709555 | — |
| Product | 3-(2-(2-Methyl-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-2-yl)phenyl)ethynyl)imidazo[1,2-b]pyridazine | HCID 72949376 | — |
Reaction Steps
The title compound was synthesized from 3-ethynylimidazo[1,2-b]pyridazine and 2-(3-iodo-4-methylphenyl)-6-((4-methylpiperazin-1-yl)methyl)-1 H-benzo[d]imidazole (as prepared in Example 1) in a manner similar to that described for in Example 1. The intermediate compound 3-ethynylimidazo[1,2-b]pyridazin was made as for Example 1 (Step 1 to 3) with the spectra below: 1H NMR (300 MHz, DMSO-d6) δ: 8.63-8.64 (1 H, m), 8.18-8.21 (1 H, m), 8.10 (1 H, s), 7.32-7.35 (1 H, m), 4.94 (1 H, s).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09174996B2 |
| Source dataset | uspto-grants-2015_11 |
| ORD ID | ord-767a93590e71499d90b64a986966e5c4 |
| Source note | uspto-grants-2015_11 |